Professional product catalogue

Psychiatry medicines

Psychiatry medicines encompass families with different functions, including antidepressants, anxiolytics and hypnotics. Mood, anxiety, sleep and alertness are related but distinct dimensions of mental health. Substances act on several nerve-transmission systems, with varied formulations and pharmacological profiles. This category explains those distinctions without reducing mental disorders to one messenger or treating a medicine family as a complete psychiatric care pathway. The shared term psychotropic provides a broad setting, while more specific mechanisms and product characteristics explain why the medicines differ.

Antidepressants

Antidepressants comprise several families acting on chemical messenger transmission in the nervous system. Selective serotonin reuptake inhibitors, agents with mixed mechanisms and other classes are not identical substances. This category explains their pharmacological and formulation distinctions and their differences from anxiolytics and hypnotics. The term antidepressant identifies a medicine family without summarising the complex causes of depression or every possible indication of an individual substance. Related clinical settings do not make all medicines for mood, anxiety and sleep interchangeable pharmaceutical products.

258 classified products

Anxiolytics

Anxiolytics include medicines from several families associated with anxiety manifestations according to their indications. Benzodiazepines are a familiar group, but they do not represent the entire category. Other agents can have different mechanisms. Understanding pharmacological action, form and substance distinguishes anxiolytic, hypnotic and antidepressant: these terms are not synonyms despite links with anxiety, alertness and sleep in some care settings. The category explains medicine characteristics without treating a common word such as stress as a diagnosis or a direct product selection rule.

155 classified products

Hypnotics

Hypnotics are medicines associated with sleep through particular mechanisms and indications. The category is not limited to benzodiazepines: it also includes other families, notably agents acting on wakefulness systems. Difficulty falling asleep, waking during the night and daytime effects describe different dimensions of insomnia. Understanding those terms, pharmacological targets and release characteristics distinguishes medicines from food supplements and other products in the wider sleep environment. A shared sleep-related description does not establish the same status, purpose or pharmaceutical characteristics for every preparation.

77 classified products